Dr. Lal Path Labs vs Thermo Fisher Scientific: Fair Value & Quality
Both stocks run through our valuation models. Here is how Dr. Lal Path Labs (LALPATHLAB) and Thermo Fisher Scientific (TMO) compare, as of Aug 18, 2026.
As of Aug 18, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Dr. Lal Path Labs trades at ₹1,877 versus a fair value of ₹665 (-65%), while Thermo Fisher Scientific trades at $586 versus $308 (-47%).
Dr. Lal Path Labs
LALPATHLAB.NSE · INR · Health Care
-65%
upside to fair value
overvalued
Price₹1,877
Fair Value₹665
Quality65/100
Thermo Fisher Scientific
TMO · USD · Health Care
-47%
upside to fair value
overvalued
Price$586
Fair Value$308
Quality63/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Dr. Lal Path LabsThermo Fisher Scientific
Valuation
62.2×P/E (TTM)29.5×
9.97×P/S (TTM)4.41×
10.99×P/B3.74×
34.1×EV/EBITDA20.0×
—PEG1.74×
0.9%Dividend yield0.3%
₹14.00Dividend per share$1.76
Profitability
18%Net margin15%
20%Operating margin18%
21%Return on equity14%
13%Return on assets5%
Growth
17%Revenue growth (YoY)6%
11.1%Avg. growth/yr (3Y)-0.3%
11.8%Avg. growth/yr (5Y)6.7%
Balance & size
—Debt / equity0.67×
$3BMarket cap$199B
healthyGrowth qualityhealthy
Dr. Lal Path Labs leads: 8 to 4 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Dr. Lal Path Labsof which business quality 66 · market factors 47Thermo Fisher Scientificof which business quality 60 · market factors 67
ProfitabilityMargins and returns on capital today
74
43
Quality GrowthAre margins and returns improving?
33
31
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
52
79
Low VolatilityCalm price path (market factor)
50
69
MomentumPrice trend over the last 3–12 months (market factor)
60
65
52W MomentumDistance to the 52-week high (market factor)
23
67
Net IssuanceBuybacks instead of dilution
39
97
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Dr. Lal Path Labs
DCF Models₹883
Earnings-Based₹410
Dividend Discount₹255
Multiples₹601
Asset-Based₹101
Growth DCF₹806
Economic Profit₹375
Growth Earnings₹633
26 of 26 models see the stock below the current price.
Thermo Fisher Scientific
DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341
24 of 24 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Dr. Lal Path Labs
Bear ₹469Fair Value ₹665Bull ₹831
₹1,877 = current price (white tick)
Thermo Fisher Scientific
Bear $171Fair Value $308Bull $385
$586 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Dr. Lal Path Labs · Health Care
Quality score65 · Top 25%
Fair value upside-65% · bottom 25%
Thermo Fisher Scientific · Health Care
Quality score63 · Top 25%
Fair value upside-47% · below median
Bottom line
As of Aug 18, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: Dr. Lal Path Labs trades at ₹1,877 versus a fair value of ₹665 (-65%), while Thermo Fisher Scientific trades at $586 versus $308 (-47%).
Dr. Lal Path Labs has the higher quality score (65/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
